The ProNexibus Plus® is one of the most effective pain-fighting high-frequency devices on the market today for those working in the field of physical therapy, rehabilitation, and pain therapy due to its unique and patented technology.
A choice of 2, 4 or 8 MHz frequencies, combined with an emission power of up to 100 watts, make the ProNexibus Plus® an extremely innovative and effective high-frequency device from the very first session.
The ProNexibus Plus® is also certified for use in patients’ homes, is easy to transport, does not require conductive creams and gels for its use, and is practical and quick to use.
The Rinovacell® is a portable electromedical high-frequency device that is extremely effective in vulnology and dermatology where cellular biostimulation of the epidermis, dermis, and hypodermis or subcutaneous tissue is needed.
Rinovacell® was designed and made to help doctors and nurses who deal daily with conditions complicated by difficult wounds(crush wounds, vascularwounds, diabetic wounds, trophic ulcers).
The Rinovacell®, is also certified for use in patients’ homes, is easy to carry, does not require conductive creams and gels for its use, and is practical and quick to use.
Through these effects, with high frequencies can be cured easily:
TESTIMONIAL
PARTNERSHIPS AND STUDIES
FOR ADDITIONAL INFORMATION
Focusmed Srl
Via Combattenti per l’Italia 11
35030 – Selvazzano Dentro
Padova – Italy
Tel/Fax: +39 0498911849
C.F./P.Iva 04590310282
Mail: admin@focusmed.it
Graphical designer Toni Cancian
Web developer Davide Parpinello
Access to the display of products and information material is reserved to operators in the sector in compliance with current legislation. FocusMed Srl requires to qualify as an operator of the sector to proceed with navigation.
Legislative Decree of 24 February 1997, No 46 Article 21
1. It is forbidden to advertise to the public devices that, according to provisions adopted by decree of the Minister of Health, may be sold only on prescription or may be used with the assistance of a doctor or other healthcare professional.
2. Advertising to the public of devices other than those referred to in paragraph 1 is subject to authorization by the Ministry of Health. On the requests for authorization expresses opinion the Commission of experts provided for by article 6, paragraph 3, of the legislative decree 30 December 1992, n. 541, which for this purpose is supplemented by a representative of the Department of the Ministry of Health responsible for medical devices and one of the Ministry of Industry, Commerce and Crafts.